Biomedical Engineering Reference
In-Depth Information
[105] Strauss, L. G. and Conti, P. S., The applications of PET in clinical on-
cology, J. Nucl. Med., Vol. 32, pp. 623-648, 1991.
[106] Glasby, J. A., Hawkins, R. A., Hoh, C. K., and Phelps, M. E., Use of
positron emission tomography in oncology, Oncology, Vol. 7, pp. 41-
46, 1993.
[107] Coleman, R. E., Clinical PET in oncology, Clin. Pos. Imaging, Vol. 1,
pp. 15-30, 1998.
[108] Anger, H. O., Scintillation camera, Rev. Sci. Instrum., Vol. 29, pp. 27-33,
1958.
[109] Smith, A. M., Gullberg, G. T., Christian, P. E., and Datz, F. L., Kinetic
modeling of teboroxime using dynamic SPECT imaging of a canine
model, J. Nucl. Med., Vol. 35, pp. 484-495, 1994.
[110] Smith, A. M., Gullberg, G. T., and Christian, P. E., Experimental ver-
ification of technetium 99m-labeled teboroxime kinetic parameters
in the myocardium with dynamic single-photon emission computed
tomography: Reproducibility, correlation to flow, and susceptibility
to extravascular contamination, J. Nucl. Cardiol., Vol. 3, pp. 130-142,
1996.
[111] Iida, H. and Eberl, S., Quantitative assessment of regional myocardial
blood flow with thallium-201 and SPECT, J. Nucl. Cardiol., Vol. 5, pp.
313-331, 1998.
[112] Eberl, S., Quantitative Physiological Parameter Estimation
from Dynamic Single Photon Emission Computed Tomography
(SPECT), Ph.D. Thesis, University of New South Wales, Australia,
2000.
[113] Laruelle, M., Baldwin, R. M., Rattner, Z., Al-Tikriti, M. S., Zea-Ponce,
Y., Zoghbi, S. S., Charney, D. S., Price, J. C., Frost, J. J., Hoffer, P. B.,
and Innis, R. B., SPECT quantification of [
123
I]iomazenil binding to
benzodiazepine receptors in nonhuman primates. I: Kinetic modeling
of single bolus experiments, J. Cereb. Blood Flow Metab., Vol. 14, pp.
439-452, 1994.
